β‐adrenergic receptor signalling and its functional consequences in the diseased heart
Key result
Chronic β-adrenergic receptor overstimulation in heart failure leads to impaired downstream signalling and decreased PKA-mediated protein phosphorylation, necessitating novel therapeutic strategies.
Population
Patients with heart failure and diseased myocardium
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant exploration of novel β-adrenergic pathway modulators in heart failure; leaves open clinical translation of these strategies.
Structured PICO
P
Population
Patients with heart failure and diseased myocardium
I
Intervention
β-blockers and novel therapeutic strategies targeting β-adrenergic receptor signalling
This review summarizes the pathophysiological consequences of chronic β-adrenergic receptor overstimulation in heart failure and highlights the need for novel, specific therapeutic strategies beyond traditional β-blockers.
Cite This Study
Najafi et al. (2016) conducted a review in Heart failure. Chronic β-adrenergic receptor overstimulation in heart failure leads to impaired downstream signalling and decreased PKA-mediated protein phosphorylation, necessitating novel therapeutic strategies.